Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Centre for Outcomes Research and Evaluation, McGill University Health Centre Research Institute, Montreal, QC, Canada.
Front Public Health. 2023 Feb 2;11:1090541. doi: 10.3389/fpubh.2023.1090541. eCollection 2023.
The aim of this study was to elucidate whether sex and gender factors influence access to health care and/or are associated with cardiovascular (CV) outcomes of individuals with diabetes mellitus (DM) across different countries.
Using data from the Canadian Community Health Survey (8.4% of respondent reporting DM) and the European Health Interview Survey (7.3% of respondents reporting DM), were analyzed. Self-reported sex and a composite measure of socio-cultural gender was constructed (range: 0-1; higher score represent participants who reported more characteristics traditionally ascribed to women). For the purposes of analyses the Gender Inequality Index (GII) was used as a country level measure of institutionalized gender.
Canadian females with DM were more likely to undergo HbA1c monitoring compared to males (OR = 1.26, 95% CI: 1.01-1.58), while conversely in the European cohort females with DM were less likely to have their blood sugar measured compared to males (OR = 0.88, 95% CI: 0.79-0.99). A higher gender score in both cohorts was associated with less frequent diabetes monitoring. Additionally, independent of sex, higher gender scores were associated with higher prevalence of self-reported heart disease, stroke, and hospitalization in all countries albeit European countries with medium-high GII, conferred a higher risk of all outcomes and hospitalization rates than low GII countries.
Regardless of sex, individuals with DM who reported characteristics typically ascribed to women and those living in countries with greater gender inequity for women exhibited poorer diabetes care and greater risk of CV outcomes and hospitalizations.
本研究旨在阐明性别因素是否影响糖尿病患者获得医疗保健的机会,以及是否与不同国家的个体心血管(CV)结局相关。
使用来自加拿大社区健康调查(8.4%的受访者报告患有糖尿病)和欧洲健康访谈调查(7.3%的受访者报告患有糖尿病)的数据进行分析。构建了自我报告的性别和社会文化性别综合衡量指标(范围:0-1;得分越高表示报告更多传统上属于女性的特征)。为了进行分析,使用性别不平等指数(GII)作为衡量国家制度性别不平等的指标。
与男性相比,加拿大患有糖尿病的女性更有可能接受 HbA1c 监测(OR=1.26,95%CI:1.01-1.58),而在欧洲队列中,患有糖尿病的女性测量血糖的可能性低于男性(OR=0.88,95%CI:0.79-0.99)。两个队列中的性别得分越高,糖尿病监测的频率越低。此外,无论性别如何,较高的性别得分与所有国家自我报告的心脏病、中风和住院率较高相关,尽管具有中高 GII 的欧洲国家比低 GII 国家具有更高的所有结局和住院率风险。
无论性别如何,报告具有女性特征的糖尿病患者和生活在女性性别不平等程度较高的国家的个体,其糖尿病护理较差,心血管结局和住院风险较高。